Efficacy And Safety Of Ledipasvir/Sofosbuvir, With Or Without Ribavirin, For Treatment Of Hepatitis C Virus-Mono And Hcv/Hiv Co-Infected Patients Who Have Failed Prior Treatment With Non-Ns5a, Sof-Based Therapies

JOURNAL OF HEPATOLOGY(2017)

引用 0|浏览28
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要